Add Company
Join Now

REDX Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Real Estate

Industry

Estimated Revenue & Valuation

  • REDX's estimated annual revenue is currently $18.4M per year.(i)
  • REDX's estimated revenue per employee is $150,000

Employee Data

  • REDX has 123 Employees.(i)

REDX's People

NameTitleEmail/Phone
1
VP TechnologyReveal Email/Phone
2
VP SalesReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Community DirectorReveal Email/Phone
5
Data ScientistReveal Email/Phone
6
Data ScientistReveal Email/Phone
7
Marketing ManagerReveal Email/Phone
8
Product ManagerReveal Email/Phone
9
Affiliate Marketing ManagerReveal Email/Phone
10
Video Production ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M46N/AN/AN/A
#2
$31.4M1906%N/AN/A
#3
$6040M286095%$1.5B$3.3B
#4
$47.7M289N/AN/AN/A
#5
$4.4M38N/AN/AN/A
#6
$79.7M425N/AN/AN/A
#7
$37.8M237N/AN/AN/A
#8
$75.9M40560%N/AN/A
#9
$3.8M34N/AN/AN/A
#10
$6.9M51N/AN/AN/A
#11
$0.9M10N/AN/AN/A
#12
$14.4M96N/AN/AN/A
#13
$3.8M33N/AN/AN/A
#14
$3.5M30N/AN/AN/A
#15
$0.4M110%$7.4MN/A
#16
$24.4M153-2%N/AN/A
#17
$22.1M147-3%$80.9MN/A
#18
$3.5M20N/AN/AN/A
#19
$6.7M51N/AN/AN/A
#20
$0.5M16-20%$52.1MN/A
Add Company

What Is REDX?

keywords:N/A

N/A

Total Funding

123

Number of Employees

$18.4M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

REDX News

2022-04-17 - City Looking At Boosting Demolition Budget To $1M ...

City leaders noted that Wheeling's Red X program had put pressure on owners to address their dilapidated properties, and also let others in...

2022-04-17 - City Looking At Boosting Demolition Budget To $1M ...

City leaders noted that Wheeling's Red X program had put pressure on owners to address their dilapidated properties, and also let others in...

2022-04-13 - Redx Pharma Says RXC004 is Being Evaluated as a Monotherapy in Phase 2 Clinical Trials

Redx Pharma PLC said late on Friday that its RXC004 cancer drug was being evaluated as a monotherapy in Phase 2 proof-of-concept clinical...

2022-04-13 - Redx Pharma Says RXC004 is Being Evaluated as a Monotherapy in Phase 2 Clinical Trials

Redx Pharma PLC said late on Friday that its RXC004 cancer drug was being evaluated as a monotherapy in Phase 2 proof-of-concept clinical...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18.3M12626%$35M
#2
$33.3M133-1%N/A
#3
N/A1359%N/A
#4
$42.5M14311%N/A
#5
$33.5M14523%N/A